Literature DB >> 2931491

Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo.

F Domurat, N J Roberts, E E Walsh, R Dagan.   

Abstract

Recurrent infections with respiratory syncytial virus (RSV) have been well documented despite serological evidence of prior exposure of the host and the absence of clear evidence of antigenic variation of the virus. Therefore, human mononuclear leukocytes, as well as purified lymphocytes and monocytes-macrophages, were exposed to RSV in vitro and examined for expression of viral antigens by using indirect immunofluorescence with monoclonal antibodies to RSV. RSV infected both human monocytes-macrophages and lymphocytes in vitro. RSV infection resulted in both a decrease in the number of T helper phenotype cells and an increase in T suppressor phenotype cells. RSV proteins were disproportionately expressed by atypical or lymphoblastoid cells, many of which were of the T suppressor phenotype. Circulating mononuclear leukocytes obtained from symptomatic children infected with RSV frequently expressed viral antigens. Viral antigens appeared to be detected more frequently in cells from the younger subjects. The findings suggest that initial or early RSV infections in children include infection of circulating immunocompetent cells. It remains to be determined whether the described RSV-induced alterations in lymphocyte subpopulations contribute to recovery from and/or recurrence of RSV infections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2931491     DOI: 10.1093/infdis/152.5.895

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection.

Authors:  Natalie J Thornburg; Bryan Shepherd; James E Crowe
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 2.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

3.  Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus.

Authors:  C R Bangham; A J McMichael
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 4.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

5.  Respiratory syncytial virus and the infant immune response.

Authors:  G L Toms; R Scott
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

6.  Respiratory syncytial virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice.

Authors:  Juan Pablo Torres; Ana M Gomez; Shama Khokhar; Vijay G Bhoj; Claudia Tagliabue; Michael L Chang; Peter A Kiener; Paula A Revell; Octavio Ramilo; Asuncion Mejias
Journal:  Respir Res       Date:  2010-09-15

7.  Reduced activation and proliferation of human lymphocytes exposed to respiratory syncytial virus compared to cells exposed to influenza virus.

Authors:  Elisa H Fleming; Eliana E Ochoa; Joan E Nichols; M Kerry O'Banion; Alan R Salkind; Norbert J Roberts
Journal:  J Med Virol       Date:  2017-09-26       Impact factor: 2.327

8.  Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection.

Authors:  R Arnold; B König; H Galatti; H Werchau; W König
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

9.  Respiratory syncytial virus seropositivity at birth is associated with adverse neonatal respiratory outcomes.

Authors:  Sara Manti; Frank Esper; Marilyn Alejandro-Rodriguez; Salvatore Leonardi; Pasqua Betta; Caterina Cuppari; Angela Lanzafame; Sarah Worley; Carmelo Salpietro; Miriam K Perez; Fariba Rezaee; Giovanni Piedimonte
Journal:  Pediatr Pulmonol       Date:  2020-08-14

10.  A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection.

Authors:  Jonathan M Ciencewicki; Xuting Wang; Jacqui Marzec; M Elina Serra; Douglas A Bell; Fernando P Polack; Steven R Kleeberger
Journal:  FASEB J       Date:  2014-01-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.